Medsense/Pharmacy Solutions/HypertensionHypertension

Hypertension, monitored where the patient lives.

A Bluetooth blood-pressure cuff in the patient's home, structured pharmacist follow-up, and prescriber-facing summaries when adjustments are needed.

For patients →
What it is

Daily readings instead of annual snapshots.

Cuffs ship from us, configured. Readings flow into the pharmacist's queue with cadence and trend triggers. Out-of-range pattern? Pharmacist calls. Med change needed? A structured note — not a fax in the dark — goes to the prescriber.

Who it's for

For every patient on antihypertensives — personalized data so they get the most out of their regimen.

Newly diagnosed

First-year HTN patients still titrating to target BP.

Resistant hypertension

On 3+ agents, BP still uncontrolled.

Post-stroke / cardiac

Discharge cohorts where BP control has the highest downstream impact.

How patients get here

Medsense reviews your panel to identify patients who could benefit from this program and matches them on conditions and medications — before any outreach begins.

Outcomes on Medsense

Outcomes that show up in HEDIS reports.

87%
BP control rate at 6 months
Vs. ~50% community baseline
8.4 mmHg
Avg systolic reduction
12-week active cohort

Launch Hypertension, monitored where the patient lives at your pharmacy.

30-day kickoff. First care management payments in 60 days.